| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: structure in first source
Also Known As:| 1. | B-Cell Lymphoma (Lymphoma, B Cell)
04/15/2002
- "We conclude that S-3APG is a powerful anti-myeloma and anti-B-cell-lymphoma agent that has both antiproliferative and antiangiogenic effects."
Order ALL the reference details at left... |
| 2. | Neoplasms (Cancer)
04/15/2002
- "In vivo, S-3APG treatment of drug resistant myeloma cell tumors in mice was able to produce complete and sustained regressions without any observed toxicity. "
04/15/2002 - "Additionally, S-3APG induced complete regressions of Burkitt's lymphoma cell tumors. " Order ALL the reference details at left... |
| 3. | Burkitt Lymphoma (Burkitt's Lymphoma)
04/15/2002
- "S-3APG was able to directly inhibit the proliferation of myeloma and Burkitt's lymphoma cell lines in vitro without showing toxicity to normal bone marrow stromal cells or hematopoietic progenitor cells. "
04/15/2002 - "Additionally, S-3APG induced complete regressions of Burkitt's lymphoma cell tumors. " Order ALL the reference details at left... |
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |